Source: investors.bicycletherapeutics.com

Bicycle Therapeutics received $555M in PIPE Funding

Read full article »

Bicycle Therapeutics's Competitors | Bicycle Therapeutics's News | Bicycle Therapeutics's Financials

Followers on Owler

134

Annual Revenue

$25-100M

Employees

250-500

CEO

Kevin Lee

CEO Approval Rating

81/100

Bicycle is an England-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and inflammatory diseases.